UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERE
1726
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.41M | ﹤0.01% |
49,968
-12,227
| -20% | -$364K |
|
1727
Cushman & Wakefield Ltd
CWK
$3.12B
| $1.41M | ﹤0.01% |
123,132
-63,086
| -34% | -$952K |
|
1728
Enanta Pharmaceuticals
ENTA
$402M
| $1.41M | ﹤0.01% |
27,169
| – | – |
|
1729
Doximity
DOCS
$4.57B
| $1.41M | ﹤0.01% |
46,574
-21,254
| -31% | -$779K |
|
1730
Pricesmart
PSMT
$5.21B
| $1.41M | ﹤0.01% |
24,410
-3,986
| -14% | -$258K |
|
1731
TTM Technologies
TTMI
$13.7B
| $1.4M | ﹤0.01% |
106,185
-15,699
| -13% | -$226K |
|
1732
Kennametal
KMT
$2.41B
| $1.4M | ﹤0.01% |
67,859
-19,544
| -22% | -$474K |
|
1733
Xenon Pharmaceuticals
XENE
$6.21B
| $1.39M | ﹤0.01% |
38,404
+11,496
| +43% | +$413K |
|
1734
Shutterstock
SSTK
$217M
| $1.38M | ﹤0.01% |
27,581
-3,352
| -11% | -$192K |
|
1735
Energy Recovery
ERII
$408M
| $1.38M | ﹤0.01% |
63,547
+11,995
| +23% | +$270K |
|
|
GMS
1736
DELISTED
GMS Inc
GMS
| $1.38M | ﹤0.01% |
34,495
-2,226
| -6% | -$106K |
|
1737
Lakeland Financial Corp
LKFN
$1.52B
| $1.38M | ﹤0.01% |
18,929
| – | – |
|
1738
Employers Holdings
EIG
$881M
| $1.38M | ﹤0.01% |
39,933
+202
| +0.5% | +$7.93K |
|
|
MODV
1739
DELISTED
ModivCare
MODV
| $1.37M | ﹤0.01% |
13,779
| – | – |
|
1740
Petco
WOOF
$765M
| $1.37M | ﹤0.01% |
122,850
-17,940
| -13% | -$262K |
|
1741
Weis Markets
WMK
$1.78B
| $1.37M | ﹤0.01% |
19,161
+1,005
| +6% | +$78.4K |
|
1742
Aclaris Therapeutics
ACRS
$867M
| $1.36M | ﹤0.01% |
86,706
+439
| +0.5% | +$6.92K |
|
1743
Clearfield
CLFD
$391M
| $1.36M | ﹤0.01% |
13,041
+6,328
| +94% | +$616K |
|
|
CSW
1744
CSW Industrials
CSW
$5.67B
| $1.36M | ﹤0.01% |
11,360
-1,111
| -9% | -$136K |
|
1745
Carpenter Technology
CRS
$27.8B
| $1.36M | ﹤0.01% |
43,560
-2,386
| -5% | -$78.9K |
|
1746
Jack in the Box
JACK
$340M
| $1.35M | ﹤0.01% |
18,279
+1,412
| +8% | +$107K |
|
1747
Establishment Labs
ESTA
$2.21B
| $1.35M | ﹤0.01% |
24,734
-1,549
| -6% | -$92.6K |
|
|
OPLN
1748
Openlane
OPLN
$4.58B
| $1.34M | ﹤0.01% |
120,179
-8,491
| -7% | -$128K |
|
1749
Agilysys
AGYS
$3.02B
| $1.34M | ﹤0.01% |
24,231
+1,310
| +6% | +$66.1K |
|
1750
Tronox
TROX
$993M
| $1.34M | ﹤0.01% |
109,114
-24,052
| -18% | -$357K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.